Advertisement
Screener

Cadrenal Therapeutics, Inc. (CVKD) Conversion of Stock, Shares Converted

2.4 / 5 stars · 11/23 Roast Me

Cadrenal Therapeutics, Inc. Conversion of Stock, Shares Converted

Cadrenal Therapeutics, Inc. (CVKD) reported Conversion of Stock, Shares Converted of 50.00 thousand shares for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:ConversionOfStockSharesConverted1 · last filed 2024-03-11

  • 2023-09-30: Conversion of Stock, Shares Converted 9 month 50.00K shares.
  • 2022-12-31: Conversion of Stock, Shares Converted 1 month 514.79K shares.
  • 2022-08-22: Conversion of Stock, Shares Converted 50.00K shares.
  • 2022-03-01: Conversion of Stock, Shares Converted 514.79K shares.
Period endConversion of Stock, Shares ConvertedConversion of Stock, Shares Converted 1 monthConversion of Stock, Shares Converted 9 month
2023-09-3050.00K shares
10-Q · filed 2023-11-09
2022-12-31514.79K shares
10-Q · filed 2023-11-09
2022-08-2250.00K shares
10-K · filed 2024-03-11
2022-03-01514.79K shares
10-K · filed 2024-03-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)United States$0.005B
Dermata Therapeutics, Inc. (DRMA)United States$0.005B-0.62
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
AMARIN CORP PLC\UK (AMRN)$0.005B-247.24
REVELATION BIOSCIENCES, INC. (REVB)United States$0.004B
HCW Biologics Inc. (HCWB)United States$0.004B-6.15
Onconetix, Inc. (ONCO)United States$0.004B
Processa Pharmaceuticals, Inc. (PCSA)United States$0.005B
Aptevo Therapeutics Inc. (APVO)United States$0.003B